Reversible myocardial ischemia/reperfusion (I/R) or ischemic preconditioning (IPC) is associated with an immediate genomic response; IPC-induced immediate early genes are associated with reduced infarct size. Because the immediate early response gene X-1 (IEX-1) plays a central role in cell apoptosis, we examine whether IEX-1 exerts protective effects against I/R injury. We found that the IEX-1 mRNA level was increased in the IPC-imposed rat heart. However, it was downregulated in the I/R rat heart, which was prevented by in situ IPC. When IEX-1 was knocked down, the protective effects imposed by IPC were lessened. Local gene delivery of Ad-IEX-1 to the left ventricle greatly diminished cardiac infarct size and improved systolic functions of I/R hearts in rats. In contrast, knocking down IEX-1 expression exacerbates myocardial infarction. Overexpression of IEX-1 in neonatal rat cardiomyocytes significantly reduced hypoxia-reoxygenation-induced intracellular and mitochondrial ROS accumulation and cell apoptosis. Furthermore, IPC-induced phosphorylation and particle translocation of PKCε were impaired by knocking down IEX-1 in vivo, and overexpressing IEX-1 showed similar cardioprotection imposed by IPC. Our results demonstrate that IPC increases IEX-1 expression, which may promote phosphorylation and particle translocation of PKCε and thus reduce intracellular ROS accumulation. These beneficial effects reduce cardiomyocyte apoptosis and necrosis to alleviate cardiac infarction.
Introduction
Timely reperfusion after myocardial ischemia is the definitive strategy to salvage myocardium at risk of lethal injury. However, abrupt restoration of blood flow to the ischemic myocardium carries the potential of introducing additional cardiomyocyte injury and death [1, 2] . Such reperfusion injury (RI) involves opening of the mitochondrial permeability transition pore (MPTP) under the conditions of calcium overload and oxidative stress that accompany reperfusion. Protection from MPTP opening and hence RI can be mediated by ischemic preconditioning (IPC) where the prolonged ischemic period is preceded by one or more brief cycles of ischemia and reperfusion [3, 4] .
There is a plethora of data implicating many different signaling pathways in preconditioning, and the relevant role of each remains hotly debated. And of them, there is extensive evidence that protein kinase C (PKC) plays a central role in preconditioning [5] . There remains some controversy over which of the many PKC isoforms may be involved in IPC. Nevertheless, there is a large body of evidence to implicate PKCε and as important players in IPC [5] . The proposed mechanism of PKCε-mediated cardioprotection is that generation of mitochondrial ROS during IPC may lead to activation of PKCδ. This increases adenosine generation and release leading to activation of phospholipase C. Generation of diacylglycerol and inositol-triphosphate results in calcium release and activation of PKCε [5] . However, there is rare study about whether PKC activation is regulated by immediate early genes.
IPC, that is, cyclic episodes of short durations of ischemia and reperfusion (I/R), potentiates redox signaling to convert the death signals into survival ones to protect the ischemic heart [6] . A previous study has shown that IPC induces the expression of proto-oncogenes or immediate early genes such as c-Fos, c-Myc, c-Jun, and Egr-1 in isolated rat hearts, which was associated with improved ventricular function and reduced infarct size [7] [8] [9] , but the underlying mechanism involving in immediate early genes protecting an ischemia heart remains elusive.
Immediate early response gene X-1 (IEX-1), also known as p22/PRG1 in rat or the mouse homologue gly96, is a novel stress-induced immediate early gene. It can be rapidly upregulated in various cell types by irradiation, viral infection, inflammatory cytokines, chemical carcinogens, growth factors, and hormones under the control of transcription factors such as NF-κB/rel, p53, Sp1, c-Myc, and AP-1 (reviewed by Wu) [10] . Like other immediate early genes, IEX-1 plays a pivotal role in cell survival under stress conditions [11] [12] [13] [14] [15] [16] . Decreased IEX-1 expression is proved to associate with enhanced apoptosis in a titin-deficient mouse model of dilated cardiomyopathy [17] . Furthermore, IEX-1 has the ability of regulating several protein kinase activities, such as ERK and Akt, through interacting with protein phosphatase 2A (PP2A) [18, 19] .
In the present study, we examine whether IEX-1 exerts protective effects against I/R injury imposed on rat neonatal and adult hearts. We found that IEX-1 expression was downregulated in the ischemic rat heart, but was rescued by IPC. The restored IEX-1 expression not only decreased the I/Rinduced apoptosis and necrosis but also alleviates cardiac infarction. The putative mechanisms include increased activation of PKC and attenuated I/R-induced ROS accumulation.
Materials and Methods
2.1. Adenoviral Vector Construction. Replication-deficient adenoviral vectors containing human IEX-1 cDNA (Ad-IEX-1) or GFP (Ad-GFP) under the control of the cytomegalovirus (CMV) promoter were constructed and prepared according to the manufacturer's instruction (BD Biosciences, San Jose, CA). Adenoviral vectors carrying bacterial β-galactosidase (Ad-β-Gal) were kindly provided by Prof. H. Cheng (Peking University, China).
Rat Model of Myocardial Ischemia and IPC.
All animals received humane care in compliance with the Institutional Authority for Laboratory Animal Care of Peking University Health Science Center. The Sprague-Dawley (SD) rat heart ischemia and IPC surgical procedures were described previously [20] . Briefly, after thoracotomy, rats underwent 30 min of myocardial ischemia, then 3 or 24 h of reperfusion. For IPC treatment, before lethal I/R, rats underwent three cycles of short I/R (4 min/4 min). Local gene delivery was performed with protocols previously described [21] . Four days before ischemia, 5 × 10 9 plaque-forming unit (pfu) adenovirus in 250 μl of virus solution was injected intramyocardially into the left ventricular muscular wall.
2.3. In Vivo Small Interfering RNA Repression. We injected siRNA/transfection agent solution into the left ventricle muscle wall to achieve sufficient siRNA concentrations for IEX-1 repression within cardiac tissues. Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (60 mg/kg). After thoracotomy, siRNA (20 μg siRNA/kg body weight) together with transfection agent solution (jet-PEI, PolyPlus transfection) was intramyocardially injected in 5 predetermined regions in the left anterior descending (LAD) area. A total of 250 μl of siRNA/transfection agent solution was delivered. Injections were performed by a single investigator in a blinded fashion. Stealth siRNA targeting rat IEX-1 (sense: cca aca uug cca aga gga ucc ucu u; antisense: aag agg auc cuc uug gca aug uug g) and control siRNA (Cat number: 12935300) were synthesized by Invitrogen (Invitrogen, CA). Two days after injection, cardiac tissue around the injected area was excised, and IEX-1 levels were determined by real-time PCR and Western blot.
Neonatal Rat Ventricular Cardiomyocyte Culture.
Neonatal rat ventricular cardiomyocytes were isolated from 1-to 2-day-old Sprague-Dawley rats [22] . Experiments were performed at day 3 in culture. For hypoxia/ reoxygenation (H/R), cells were cultured in hypoxia buffer (in mmol/l NaCl 118, NaHCO 3 24, KCl 16, KH 2 PO 4 1, CaCl 2 2.5, MgCl 2 1.2, Na + EDTA 0.5, and Na + lactate 20, pH 6.2) and underwent <1% O 2 + 5% CO 2 + argon treatment for 4 h, then were transferred to 5% CO 2 + 95% air for reoxygenation. And 10 min hypoxia followed with 10 min reoxygenation was considered as one cycle of preconditioning. 2.7. Statistical Analysis. All values are expressed as mean ± SEM. Comparisons between more than 2 groups were analyzed by one-way ANOVA followed by Tukey-Kramer post hoc testing. A P < 0 05 was considered statistically significant.
The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written. 
Results

IEX-1-Mediated IPC-Induced Cardioprotection.
We used a model of in situ IPC of intermittent coronary occlusion to examine first the expression of IEX-1 in the rat heart. As shown in Figure 1 (a), the IEX-1 mRNA level was increased rapidly in the IPC-imposed heart, peaked at 5 min, and declined thereafter, which remained higher than the basal level at 1 h (Figure 1 , and the level of IEX-1 mRNA was higher in hearts that underwent IPC prior to I/R than that in hearts receiving I/R only ( Figure 1(c) ). The IEX-1 protein level decreased at 3 h reperfusion which was rescued by IPC prior to I/R (Supplemental Figure 1A and B). Because IPC could induce IEX-1 expression, we then investigated whether the increased level of IEX-1 is involved in IPC-mediated cardiac protection. Small interfering RNA targeting rat IEX-1 (siIEX-1) was used to knock down IEX-1 expression in hearts. As shown in Figures 1(d) , 1(e), and 1(f), in situ IPC protected the heart, revealed by decreased infarct size, in the scrambled siRNA (csiR) group, but not in the siIEX-1 group. These were parallel, confirmed by decreased release of lactate dehydrogenase (LDH) and creatine kinase (CK) to serum in the csiR group, but not in the siIEX-1 group (Figures 1(g) and 1(h)).
IEX-1 knockdown impaired the protective effects of IPC, which was further confirmed by echocardiography analysis.
As shown in Figures 2(a) and 2(b), impaired systolic function post-I/R was observed in the I/R group, assessed by ejection fraction (EF), fraction shortening (FS), and systolic left ventricular internal dimension (LVID-s), while IPC-imposed rats showed improved systolic function post-I/R in the csiR group. Of note, depraved systolic function was observed in the rats treated with siIEX-1 prior to IPC, which was similar to that in I/R alone rats.
IEX-1 Overexpression Attenuates Myocardial Infarction.
To investigate a functional contribution of IEX-1 to postischemic cardioprotection, we developed an adenoviral vector expressing human IEX-1 (Ad-IEX-1). In the experimental group, Ad-IEX-1 was directly injected into the left ventricle wall, whereas control groups received Ad-GFP or saline. Four days post the injection, rat hearts were excised. The overexpression of IEX-1 in the cardiac muscle was confirmed by Western blot (Figure 3(a) ) and immunostaining (Supplemental Figure 2A ). As shown in Figures 3(b) , 3(c), and 3(d), IEX-1 overexpression caused significant cardioprotection. A significant decrease in infarct size of the hearts was found in these animals, when compared with that of hearts receiving saline or Ad-GFP. In addition, these rats exhibited lower levels of serum LDH and CK (Figures 3(e) and 3(f) ). As well, the accident rate of cell apoptosis in the area at risk, assessed by TUNEL staining, was significantly reduced in IEX-1 overexpressed rats (Figure 3(g) ).
To examine the functional consequences resulting from Ad-IEX-1 gene delivery, we measured cardiac systolic cardiac hemodynamics parameters showed that mean arterial pressure, left ventricular systolic pressure, maximal rates of pressure increase and decrease were significantly impaired post-I/R, whereas these parameters were improved in Ad-IEX-1 delivery rats (Supplemental Table 1 ).
SiRNA Knocking Down IEX-1 Exacerbates Myocardial
Infarction. In the reciprocal approach, we used siRNA to repress the cardiac expression of IEX-1 in vivo. An amount of 5 μg of IEX-1 siRNA (siIEX-1) together with transfection reagent was directly injected into the rat left ventricular wall. The IEX-1 mRNA level was reduced at 48 h postinjection ( Figure 5(a) ), and the corresponding reduction of protein was confirmed by Western blot ( Figure 5(b) ) and immunostaining (Supplemental Figure 2B ). Responding to I/R (30 min/24 h), rats with siIEX-1 injection showed significantly increased infarct size expressed as the percentage of the left ventricle area (~7%), when compared with animals with control siRNA (Figures 5(c) and 5(d) ). Similarly, plasma LDH and CK activity were increased in rats receiving siIEX-1 ( Figure 5 (e) and 5(f)).
3.4. IEX-1 Inhibits H/R-Induced ROS Accumulation. Because ROS accumulation at the end of ischemia and during reperfusion exacerbates cardiomyocyte injury [23, 24] and PKCε diminishing these ROS levels is a critical step in preconditioning [3] , thus, we tested the role of IEX-1 in H/R-induced ROS accumulation. Neonatal rat cardiomyocytes were infected with 10 MOI of adenovirus and subjected to hypoxia for 4 h, then submitted to chemiluminescence or fluorescence analysis for intracellular ROS accumulation. Intracellular ROS was significantly reduced in cells overexpressing IEX-1 (~74% reduction in chemiluminescence, Figure 6 (a), and 69% reduction in DCF fluorescence, Figure 6 (b)). During H/R, mitochondrion seems to be the main source of ROS in cardiomyocytes [25] . After 4 h hypoxia, cardiomyocytes were incubated with MitoTracker Red CM-H2XRos to probe the mitochondrial ROS (Supplemental Figure 3) . Confocal microscopy revealed that neonatal rat cardiomyocytes undergoing H/R displayed a 5.5-fold increase in fluorescence intensity, which was significantly reduced in cells receiving Ad-IEX-1 ( Figure 6(c) ), indicating that IEX-1 is able to decrease mitochondrial ROS accumulation.
IEX-1 Reduces H/R-Induced Cardiomyocyte Injury.
The increased ROS is a primary stimulus for the mitochondrial death pathway. Then, we used an in vitro H/R model to study the effects of IEX-1 on H/R-induced cardiomyocyte death. Neonatal cardiomyocytes were infected with Ad-GFP or Ad-IEX-1 at 5, 10, or 20 MOI. After H/R insult, Ad-IEX-1-infected cells showed less morphological changes than those infected with Ad-GFP (Supplemental Figure 4A) . Overexpression of IEX-1, but not GFP, greatly reduced LDH release in conditioned media (Supplemental Figure 4B) . As well, caspase-3 cleavage, an indication of apoptosis, reduced in cells overexpressing IEX-1 (Figure 7(a) ). After H/R, caspase-3 cleavage increased as reoxygenation time was prolonged in both Ad-GFP-and Ad-IEX-1-infected cells. However, the cleaved caspase-3 was less in cells overexpressing IEX-1 at all time points (Figure 7(b) ). Concurrently, caspase-3/7 activity attenuated in cells infected with Ad-IEX-1, compared with those with Ad-GFP (Figure 7(c) ). Under H/R, the percentage of TUNEL-positive (apoptotic) cells was also reduced by IEX-1 (Figure 8(d) ). Moreover, there was a decrease in mitochondrial cytochrome c leakage to cytoplasm in IEX-1 overexpressed cells (Figures 7(e) and 7(f) ). Together, these data indicate that IEX-1 overexpression imposes protective effects on neonatal rat cardiomyocytes under H/R.
IEX-1 Promotes PKCε Phosphorylation and Mitochondrial
Translocation. Then, we found clear particle translocation of PKCε in cardiac cells subjected to IPC prior to I/R, which was also observed similarly in the IEX-1 overexpressed heart; in contrast to these, particle translocation of PKCε was significantly inhibited when siIEX-1 was administered to knock down heart IEX-1 (Figure 8(a) ). Then, we further detected phosphor-PKCε in hearts after IPC + I/R; of note, the increased level of phosphor-PKCε by IPC was abolished by IEX-1 knocking down (Figure 8(b) ).
Multiple studies have demonstrated that activation of protein kinase Cε (PKCε) is critical for the protective phenotype of IPC against myocardial I/R injury [5] . Thus, we confirmed these results in cultured cardiomyocytes. First, in vitro IPC, termed hypoxia preconditioning (HPC), induced by short-term hypoxia and reoxygenation similarly increased IEX-1 expression at both the mRNA level (Figure 8(c, d) ) and the protein level (Supplemental Figure  5A and B). Thereafter, we overexpressed IEX-1 in cultured cardiomyocytes, and phosphor-PKCε was increased in cells receiving Ad-IEX-1 at both normal culture and post-H/R (Figure 8(e) ). Furthermore, Western blot showed that IEX-1 overexpression increased the PKCε protein level in the mitochondrial fraction (Figure 8(f) ). And PKCε inhibitor abolished the protective effect of IEX-1 on H/R-induced caspase-3 activation (Figure 8(g) ).
Discussion
This study shows that IEX-1 is pivotal in IPC-induced cardioprotection against I/R-induced injury. We found that IPC, commonly used in coronary intervention and coronary artery bypass grafting [26, 27] , could increase IEX-1 expression in ischemic hearts in vivo. When IEX-1 expression was inhibited by siRNA, the protective effects imposed by IPC were lessened. Using gain-of-function approaches, we demonstrated that hearts with exogenously expressed IEX-1 enhanced their tolerance to I/R. In the complementary experiments, siRNA knocking down the endogenous IEX-1 exacerbated the cardiac injury. The molecular basis underlying such a protective effect involves, but not limits to, the promotion of PKCε phosphorylation and attenuation of H/R-induced ROS accumulation and cell death.
Reversible myocardial I/R during human cardiac surgery or mouse IPC is associated with an immediate genomic response [28, 29] . IPC induces the expression of protooncogenes or immediate early genes such as c-Fos, c-Myc, c-Jun, and Egr-1 in isolated rat hearts, which is associated with improved ventricular function and reduced infarct size [7] [8] [9] . Our results show that Iex-1 mRNA was rapidly induced by IPC, suggesting that increased IEX-1 expression would contribute to the protective effects of IPC. The thesis was supported by the fact that siRNA knocking down the endogenous IEX-1 exacerbated the cardiac injury and abolished the protective effects induced by IPC, while overexpressing IEX-1 exhibited similar protective effects to IPC. The antiapoptotic effect of IEX-1 on the cardiomyocyte is in line with several previous studies. IEX-1-transgenic mice showed reduced T-cell apoptosis triggered by FAS ligation or T-cell receptor/CD3 complex [30] . IEX-1 overexpression considerably decreased the p73β-mediated and staurosporin-induced CHO cell death [12, 16] . However, IEX-1 has also been shown to increase the rate of apoptosis in CHO cells, HaCaT keratinocytes [15] , Hela cells [13] , or HEK293 cells [14] . The distinct role of IEX-1 in terms of pro-or antiapoptosis may thus depend on cell types, expression level, and kinds of stimulus. Through transcription factors such as NF-κB/REL complexes, p53, SP1, C-MYC, and AP-1, IEX-1 can be induced in a wide variety of cell types by irradiation, viral infection, inflammatory cytokines, chemical carcinogens, growth factors, and hormones (reviewed in 16), and C-MYC, NF-κB, and AP-1 are IPC responsive [31] ; these transcriptional factors are likely to be involved in the immediate induction of IEX-1 by IPC.
Ample evidence implicates that mitochondrion-originated ROS, NADH-dependent microsomes, and NOS are very likely to constitute in the initial injury in cardiomyocytes at the end of ischemia and during reperfusion [25, [32] [33] [34] [35] . ROS that resulted from stress can cause lipid peroxidation, protein oxidization, and DNA strand breaks, which affect normal cardiac functions. Although ROS is generated during hypoxia [36] , a robust burst of ROS occurs after reoxygenation [37] . In the heart, mitochondria are probably the principal source of ROS after reoxygenation and/or reperfusion [25] . The increased ROS in turn is a primary stimulus for MPTP opening, leading to an impaired mitochondrial membrane [38, 39] . Indeed, opening MPTP, releasing cytochrome c from mitochondria, and activating caspase cascade may be a series of events that induce irreversible injury during reperfusion [39] [40] [41] . IEX-1 overexpression reduced ROS accumulation, evidenced by decreased luminalderived chemiluminescence, DCF fluorescence, and Red CM-H2XRos fluorescence, and limited cytochrome c leakage from mitochondria to cytoplasm. Thus, IEX-1 may be involved in maintaining mitochondrial membrane integrity and preventing the mitochondrial death pathway through inhibiting mitochondrial ROS production.
Mitochondria mediate diverse cellular functions including energy generation and ROS production and contribute to signal transduction. Mitochondria are also key regulators of cell viability and play a central role in necrotic and apoptotic cell death pathways induced by cardiac I/R injury. PKCε plays a critical role in cardioprotective signaling pathways that protect the heart from I/R [42] . Emerging evidence suggests that the cardioprotective target of PKCε resides at the mitochondria, including mitoK ATP (mitochondrial ATPsensitive K + channel) [43] , components of the MPTP [44] , and components of the electron transport chain [45] , and phosphorylation and mitochondrial translocation of PKCε are required for cardioprotection [46] . It has been reported that cytoplasm location, including mitochondrial location, of IEX-1 is critical for its antiapoptotic and antioxidant effects [12] . In the present study, we found that IEX-1 and PKCε colocalized in mitochondrion; IEX-1 expression is necessary for IPC-induced phosphorylation of PKCε both in vivo and in vitro and promotes mitochondrial translocation of PKCε. Because activating PKCε is critical for IPCinduced cardioprotection against I/R, promoting PKCε activation may be the main mechanism for IEX-1-mediating IPC-induced cardioprotection, as PKCε inhibitor blocked the protective effect of IEX-1. However, the mechanisms for IEX-1-promoting PKCε phosphorylation and mitochondrial translocation remain to be elucidated. Of note, the interaction of IEX-1 with PP2A is the central role for IEX-1-modulating ERK and AKT activity [18, 19] , which may also be the mechanism for IEX-1-promoting PKCε activity. On the other side, the potential effects of IEX-1 on ERK and AKT activity may also contribute to the cardioprotection, as the AKT-ERK-NO pathway is another important mechanism for IPC-induced cardioprotection [47] .
In summary, we demonstrate that IEX-1 is critical in preventing oxidative stress-induced cardiac injury and mediates IPC-induced cardioprotection in rats. In addition to this newly found antioxidative effect, IEX-1 also exhibits inhibitory effects on hypertension, neointima formation, and cardiac hypertrophy [48] [49] [50] . Thereby, IEX-1 would be a cardioprotective gene. The identification of an early response gene involved in I/R-induced heart insult may reveal a new therapeutic strategy to explore targets for ischemic heart diseases.
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